AcquisitionOther
Carlyle and SK Capital Partners acquired bluebird bio, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Carlyle and SK Capital Partners -> bluebird bio, Inc.
Acquire pioneer in gene therapies for severe genetic diseases to scale access to lifechanging treatments.
Open source record (SEC) ↗